Moderna (MRNA) is in talks with at least one large drugmaker on a deal of significant scope, including a buyout, a person familiar with the discussions told STAT News. Though the precise nature of the potential agreement was unclear, a buyout is on the table, Jason Mast reported after having interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA: